VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study

Oral Oncology

Volumn 45, Issue 7, 2009, Pages 584-588

  Faratzis, Gregory ^a   Tsiambas, Evangelos ^b   Rapidis, Alexander D ^a   Machaira, Aggeliki ^a   Xiromeritis, Konstantinos ^c   Patsouris, Efstratios ^c  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b 401 Armed Forces Hospital   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Computerized image analysis; Head and neck cancer; Immunohistochemistry; ki 67; Oral cancer; Prognosis in oral cancer; Squamous cell carcinoma of the tongue; Vascular endothelial growth factor; VEGF

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ANALYSIS; CONTROLLED STUDY; DIGITAL IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67449101674     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.08.002     Document Type: Article

References (41)

1. Greenlee R.T., Murray T., Bolden S., and Wingo P.A. Cancer statistics, 2000. CA Cancer J Clin 50 1 (2000) 7-33
2. Vokes E.E., Weichselbaum R.R., Lippman S.M., and Hong W.K. Head and neck cancer. New Engl J Med 328 3 (1993) 184-194
3. Do K.A., Johnson M.M., Lee J.J., Wu X.F., Dong Q., Hong W.K., et al. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101 12 (2004) 2837-2842
4. Viswanathan H., and Wilson J.A. Alcohol - the neglected risk factor in head and neck cancer. Clin Otolaryngol Allied Sci 29 4 (2004) 295-300
5. Veltman J.A., Bot F.J., Huynen F.C., Ramaekers F.C., Manni J.J., and Hopman A.H. Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J Clin Oncol 18 8 (2000) 1644-1651
6. Ellis L.M., Rosen L., and Gordon M.S. Overview of anti-VEGF therapy and angiogenesis. Part 1: Angiogenesis inhibition in solid tumor malignancies. Clin Adv Hematol Oncol 4 1 (2006) Suppl. 1-10; quz 11-2
7. Voelkel N.F., Vandivier R.W., and Tuder R.M. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290 2 (2006) L209-L221
8. Zhu C.Q., Shih W., Ling C.H., and Tsao M.S. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 59 8 (2006) 790-800
9. Strieter R.M. Masters of angiogenesis. Nat Med 11 9 (2005) 925-927
10. Langer C.J., and Natale R.B. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors. Semin Oncol 32 6 Suppl. 10 (2005) S23-S29
11. Thorpe P.E. Vascular targeting agents as cancer therapeutics. Clin Cancer Res 10 2 (2004) 415-427
12. Lopez de Cicco R., Watson J.C., Bassi D.E., Litwin S., and Klein-Szanto A.J. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression. Clin Cancer Res 10 13 (2004) 4480-4488
13. Chuang H.C., Su C.Y., Huang H.Y., Chien C.Y., Chen C.M., and Huang C.C. High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope 116 7 (2006) 1175-1179
14. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1 3 (1990) 199-206
15. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 3 (2000) 311-322
16. Duchrow M., Gerdes J., and Schluter C. The proliferation-associated Ki-67 protein: definition in molecular terms. Cell Prolif 27 5 (1994) 235-242
17. Davies L., Hardin N.J., and Beatty B.G. Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue?. Ann Otol Rhinol Laryngol 115 1 (2006) 12-17
18. Sittel C., Ruiz S., Volling P., Kvasnicka H.M., Jungehulsing M., and Eckel H.E. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol 35 6 (1999) 583-589
19. Kwong R.A., Kalish L.H., Nguyen T.V., Kench J.G., Bova R.J., Cole I.E., et al. P14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 11 11 (2005) 4107-4116
20. Tsantoulis P.K., Kastrinakis N.G., Tourvas A.D., Laskaris G., and Gorgoulis V.G. Advances in the biology of oral cancer. Oral Oncol 43 6 (2007) 523-534
21. Shang Z.J., Li Z.B., and Li J.R. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac Surg 35 6 (2006) 533-538
22. Li C., Shintani S., Terakado N., Klosek S.K., Ishikawa T., Nakashiro K., et al. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34 5 (2005) 559-565
23. Kishimoto K., Sasaki A., Yoshihama Y., Mese H., Tsukamoto G., and Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol 39 4 (2003) 391-406
24. Zhang Q., Zhang Z.F., Rao J.Y., Sato J.D., Brown J., Messadi D.V., et al. Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas. Int J Cancer 111 6 (2004) 849-857
25. Zhang Q., Tang X., Lu Q.Y., Zhang Z.F., Brown J., and Le A.D. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 4 10 (2005) 1465-1474
26. Masuda M., Ruan H.Y., Ito A., Nakashima T., Toh S., Wakasaki T., et al. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma. Oral Oncol 43 8 (2007) 785-790
27. Siemann D.W., and Shi W. Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumors. Int J Radiat Oncol Biol Phys 60 4 (2004) 1233-1240
28. Yazici Y.D., Kim S., Jasser S.A., Wang Z., Carter Jr. K.B., Bucana C.D., et al. Antivascular therapy of oral tongue squamous cell carcinoma with PTK787. Laryngoscope 115 12 (2005) 2249-2255
29. Choi H.R., Tucker S.A., Huang Z., Gillenwater A.M., Luna M.A., Batsakis J.G., et al. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol 22 2 (2003) 409-414
30. Harada H., Omura K., Nakajima Y., Hasegawa S., and Mogi S. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma. J Exp Clin Cancer Res 25 3 (2006) 351-356
31. Wang L., Liu T., Nishioka M., Aguirre R.L., Win S.S., and Okada N. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol 42 6 (2006) 625-631
32. Grabenbauer G.G., Suckorada O., Niedobitek G., Rodel F., Iro H., Sauer R., et al. Imbalance between proliferation and apoptosis may be responsible for treatment failure after postoperative radiotherapy in squamous cell carcinoma of the oropharynx. Oral Oncol 39 5 (2003) 459-469
33. Andressakis D., Lazaris A.C., Tsiambas E., Kavantzas N., Rapidis A., and Patsouris E. Evaluation of caspase-3 and caspase-8 deregulation in tongue squamous cell carcinoma, based on immunohistochemistry and computerised image analysis. J Laryngol Otol (2008) 1-6
34. Szelachowska J., Dziegiel P., Jelen-Krzeszewska J., Jelen M., Matkowski R., Pomiecko A., et al. Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res 26 3B (2006) 2473-2478
35. Gil J., Wu H., and Wang B.Y. Image analysis and morphometry in the diagnosis of breast cancer. Microsc Res Tech 59 2 (2002) 109-118
36. Lehr H.A., Jacobs T.W., Yaziji H., Schnitt S.J., and Gown A.M. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol 115 6 (2001) 814-822
37. Bloom K., and Harrington D. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. Am J Clin Pathol 121 5 (2004) 620-630
38. Tsiambas E., Karameris A., Dervenis C., Lazaris A.C., Giannakou N., Gerontopoulos K., et al. HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis. Jop 7 3 (2006) 283-294
39. Tsiambas E., Stavrakis I., Lazaris A.C., Karameris A., and Patsouris E. Evaluation of epidermal growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue microarrays. J Laryngol Otol 121 6 (2007) 563-570
40. Shutter J., Atkins K.A., Ghartey K., and Herzog T.J. Clinical applications of immunohistochemistry in gynecological malignancies. Int J Gynecol Cancer 17 2 (2007) 311-315
41. Tamas E.F., and Epstein J.I. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Am J Surg Pathol 31 3 (2007) 390-397